Remdesivir

From WikiMD's Wellness Encyclopedia

Error creating thumbnail:
Remdesivir.svg

Remdesivir is an antiviral drug developed by the biopharmaceutical company Gilead Sciences. It is a nucleotide analog, specifically an adenosine analog, which interferes with the action of viral RNA-dependent RNA polymerase and has broad-spectrum antiviral activity against several RNA viruses.

Development and Mechanism of Action[edit | edit source]

Remdesivir was originally developed to treat Ebola virus infections. However, it showed limited efficacy in clinical trials for Ebola. The drug works by inhibiting the RNA-dependent RNA polymerase enzyme, which is essential for the replication of RNA viruses. By incorporating into the viral RNA chain, remdesivir causes premature termination of the RNA transcription process, thereby inhibiting viral replication.

Clinical Use[edit | edit source]

Remdesivir gained significant attention during the COVID-19 pandemic as a potential treatment for SARS-CoV-2, the virus responsible for COVID-19. Clinical trials have shown that remdesivir can reduce the time to recovery in hospitalized patients with severe COVID-19. It was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) in May 2020 and later received full approval in October 2020.

Administration and Dosage[edit | edit source]

Remdesivir is administered intravenously. The typical dosage regimen for COVID-19 involves a loading dose followed by daily maintenance doses. The duration of treatment can vary depending on the severity of the disease and the patient's response to the medication.

Side Effects and Safety[edit | edit source]

Common side effects of remdesivir include nausea, elevated liver enzymes, and potential allergic reactions. It is important to monitor liver function during treatment. The safety and efficacy of remdesivir in certain populations, such as pregnant women and children, are still under investigation.

Regulatory Status[edit | edit source]

Remdesivir has been approved or authorized for emergency use in several countries around the world. Its approval status may vary depending on the regulatory framework of each country.

Research and Future Directions[edit | edit source]

Ongoing research is exploring the use of remdesivir in combination with other antiviral or anti-inflammatory agents to enhance its efficacy against COVID-19 and other viral infections. Studies are also being conducted to evaluate its potential use in treating other RNA virus infections.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD